Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
  • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
  • C07D311/78—Ring systems having three or more relevant rings
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
  • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
  • A23L2/52—Adding ingredients
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
  • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
  • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
  • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
  • A61K31/365—Lactones
  • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P39/00—General protective or antinoxious agents
  • A61P39/06—Free radical scavengers or antioxidants
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
  • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

• the present invention relates to a method for producing an ellagic acid composition.
• Ellagic acid is a compound having a polyphenol structure contained in plants such as strawberries, apples, guava and cod. It has been clarified that ellagic acid has physiological functions such as a whitening effect and an antioxidant effect.
• ellagic acid has low solubility in water and is difficult to use in aqueous products.
• a technique for solubilizing ellagic acid in water has been studied, and for example, an ⁇ -glycoside in which at least one molecule of sugar is bound to ellagic acid (Patent Document 1) has been reported.
• a method of mixing ellagic acid into fine particles by mixing with a crystal growth inhibitor and a water-soluble polymer and stably dispersing Patent Document 2.
• Patent Documents 3 and 4 On the other hand, against the background of health orientation in recent years, attention has been paid to the ⁇ -amylase inhibitory action of guava leaf extract, and soft drinks and the like containing guava leaf extract have been developed (for example, Patent Documents 3 and 4).
• the guava leaf extract contains ellagic acid, which precipitates at room temperature due to its poor water solubility. Therefore, in order to prevent the appearance of the beverage from being damaged, a method of removing fine crystal nuclei of free ellagic acid from the guava leaf extract by microfiltration (Patent Document 3), the guava leaf is heated at 90 to 98 ° C.
• a method has been proposed in which extraction is performed with hot water, and the resulting extract is concentrated to a Brix sugar content in the range of 20 to 30 and then freeze-dried (Patent Document 4).
• Patent Literature Patent Literature
• Patent Document 1 JP-A-2005-281204 (Patent Document 2) JP-A-2003-81826 (Patent Document 3) JP-A-2003-208 (Patent Document 4) International Publication No. 2007/135767
• the present invention comprises a step of preparing a heat-treated raw material by mixing a raw material containing a guava leaf extract and containing 1 to 5% by mass of free ellagic acid in a solid content with an aqueous medium, and the heating
• the present invention provides a method for producing an ellagic acid composition comprising a step of heat-treating a treatment raw material at 100 to 180 ° C., and an ellagic acid composition obtained by the production method.
• the present inventors have made various studies on the solubilization technology of ellagic acid. Although only the free ellagic acid is heat-treated at 100 ° C. or higher in the presence of an aqueous medium, the solubility in water is not improved. It was found that the concentration of ellagic acid dissolved in water was dramatically increased by heat-treating ellagic acid together with guava leaf extract at 100 ° C. or higher. Further, it has been found that when the composition subjected to such heat treatment is spray-dried or freeze-dried, it can be dried while maintaining high solubility in water, and an ellagic acid composition having excellent water solubility can be obtained. .
• the concentration of free ellagic acid in water can be increased, and an ellagic acid composition having excellent solubility can be produced at low cost.
• the present invention comprises a step of preparing a heat-treated raw material by mixing a raw material containing a guava leaf extract and containing 1 to 5% by mass of free ellagic acid in a solid content with an aqueous medium, and the heating
• a method for producing an ellagic acid composition comprising a step of heat-treating a treated raw material at 100 to 180 ° C.
• the guava leaf extract used in the present invention is a leaf extract of guava (Psidium guajava).
• the guava leaf extract can be obtained by subjecting the guava leaf as it is or after drying or subjecting them to an extraction step. Examples of the treatment include cutting, crushing, grinding, and crushing.
• guava leaf extract commercially available products such as guava leaf extract powder (Matsuura Sangyo Co., Ltd.), guavaphenone (Bizen Kasei Co., Ltd.), and various solvent extracts obtained by conventional methods may be used. Good.
• the content of free ellagic acid in the guava leaf extract is not particularly limited, but is preferably 1 to 5% by mass (hereinafter simply referred to as “%”), and more preferably 1 to 3%.
• the solvent for extraction is not particularly limited.
• water water vapor; alcohols such as methanol and ethanol; subcritical or supercritical carbon dioxide; soybean oil, rapeseed oil, sunflower oil, palm oil, Edible oils and fats such as lard; and mixtures thereof.
• alcohols such as methanol and ethanol
• subcritical or supercritical carbon dioxide soybean oil, rapeseed oil, sunflower oil, palm oil, Edible oils and fats such as lard
• water, alcohols, and a mixture thereof are preferable, and water, alcohol having 4 or less carbon atoms, and a mixture thereof are more preferable.
• any means such as solid-liquid extraction, liquid-liquid extraction, immersion, decoction, leaching, steam distillation, reflux extraction, ultrasonic extraction, microwave extraction, stirring, etc. is used. be able to.
• the extraction conditions are not particularly limited, but the extraction temperature is preferably 0 ° C. or higher, more preferably 20 ° C. or higher, further 50 ° C. or higher, and further preferably 60 ° C. or higher from the viewpoint of increasing the extraction efficiency. Further, the boiling point of the solvent is preferable, and 100 ° C. or lower is preferable.
• the guava leaf extract thus obtained may be a crude product, or may be a product obtained by further purifying the crude product by appropriately combining known separation and purification methods.
• the purification means include organic solvent precipitation, centrifugation, ultrafiltration, adsorbent treatment, high performance liquid chromatograph, column chromatograph and the like.
• the guava leaf extract may be used as an extract or a fraction as it is, may be used as a diluted solution diluted with an appropriate solvent, or a concentrated extract or a dry powder, or prepared as a paste. It may be a thing.
• a heat treatment raw material is prepared by mixing a raw material containing an extract of guava leaf and containing 1 to 5% of free ellagic acid in a solid content with an aqueous medium.
• the aqueous medium used in the present invention refers to water or an aqueous solution of water and an organic solvent. Examples of water include tap water, distilled water, ion exchange water, and purified water.
• the organic solvent is not particularly limited as long as it is uniformly mixed with water.
• alcohol having 4 or less carbon atoms is preferable, propanol and ethanol are more preferable, and ethanol is more preferable from the viewpoint of being applicable to foods.
• the concentration of the organic solvent in the aqueous solution is preferably 0 to 60%, more preferably 0 to 30%, further preferably 0 to 25%, further preferably 0 to 20%, further preferably 0 to 10%, and more preferably 0 to 5% is more preferable, and 0 to 2% is more preferable.
• Mixing of the raw material and the aqueous medium can be performed by a known method such as stirring.
• the content of the guava leaf extract in the raw material is preferably 60% or more, more preferably 70% or more, based on the solid content. Further, it is preferably 80% or more, further 90% or more, more preferably 95% or more, and more preferably 97% or more. From the viewpoint of increasing the content of ellagic acid, it is preferably 100% or less, more preferably 99.5% or less. Further, the content of the guava leaf extract in the raw material is further 60 to 100%, further 70 to 100%, further 80 to 100%, further 90 to 100%, further 95 to 100%, further 97 based on the solid content. ⁇ 100%, more preferably 97 ⁇ 99.5%.
• the solid content of the guava leaf extract in this specification is the mass when the guava leaf extract is in a solid state such as a powder, and the guava leaf extract is 105 ° C. when the guava leaf extract is not in a solid state. It is set as the mass after drying for 3 hours with an electric constant temperature dryer and removing volatile components.
• the content of free ellagic acid in the solid content in the raw material is 1 to 5%, but from the viewpoint of effectively improving physiological function, it is further 1.2% or more, further 1.5% or more, and further 1.8. % Or more, further 2% or more, more preferably 2.2% or more, and further preferably 2.5% or more. From the viewpoint of suppressing crystallization from the solution, it is 5% or less, and further preferably 4% or less. Further, the content of free ellagic acid in the solid content is further 1.2 to 5%, further 1.5 to 5%, further 1.8 to 5%, further 2.2 to 5%, and further 2. 5 to 4% is preferable.
• the free ellagic acid in this specification refers to the ellagic acid which exists in the free state instead of the thing in which such saccharide
• the solid content of the raw material in the present specification refers to a residue obtained by drying the raw material for 3 hours with an electric constant temperature dryer at 105 ° C. to remove volatile components.
• free ellagic acid may be added to the raw material.
• the free ellagic acid includes ellagic acid salts and hydrates.
• Examples of commercially available free ellagic acid include pomegranate ellagic acid (Savinsa Japan Corporation), ellagic acid dihydrate (Wako Pure Chemical Industries, Ltd.), and the like.
• the solid content in the heat-treated raw material in which the raw material and the aqueous medium are mixed is usually preferably 3 g / L or more, more preferably 3.5 g / L or more, and further preferably 4.0 g / L or more from the viewpoint of fluidity. Further, it is preferably 60 g / L or less, more preferably 50 g / L or less. Further, it is preferably 3 to 60 g / L, more preferably 3.5 to 50 g / L, still more preferably 4.0 to 50 g / L.
• the guava leaf extract is preferably dispersed or dissolved in an aqueous medium so as to have such a solid content concentration.
• the pH (20 ° C.) of the heat-treated raw material is preferably pH 4 or higher, more preferably pH 4.7 or higher, and further preferably pH 4.9 or higher, pH 5.8 or lower, and further pH 5 from the viewpoint of improving flavor and ellagic acid solubility. .5 or less, further 5.4 or less, and further 5.3 or less are preferable.
• the pH (20 ° C.) of the heat treatment raw material is preferably pH 4 to 5.8, more preferably pH 5 to 5.5, further pH 4.7 to 5.4, and further pH 4.7 to 5.3. It is preferable.
• the method for heat-treating the heat-treated raw material is not particularly limited, and a known method can be applied.
• the temperature of the heat treatment is 100 to 180 ° C., but from the viewpoint of improving the solubility of ellagic acid, it is preferably 110 ° C. or higher, more preferably 120 ° C. or higher, and from the viewpoint of thermal stability, 170 ° C. or lower, further 160 ° C. or lower, Furthermore, 150 degrees C or less is preferable. Also, it is preferably 100 to 170 ° C, more preferably 110 to 170 ° C, still more preferably 120 to 160 ° C, and still more preferably 120 to 150 ° C. Examples of the heating means include water vapor and electricity.
• the pressure during the heat treatment is preferably 0 to 10 MPa, more preferably 0.1 to 8 MPa, further preferably 0.1 to 6 MPa, further preferably 0.2 to 6 MPa, and further preferably 0.2 to 4 MPa in terms of gauge pressure.
• 0.25 to 2 MPa is more preferable, 0.3 to 1.5 MPa is more preferable, and 0.3 to 0.6 MPa is further preferable.
• Gas may be used for pressurization, and examples of the gas used include inert gas, water vapor, nitrogen gas, helium gas, and the like.
• the pressurization may be adjusted by a back pressure valve without using gas.
• the heat treatment can be performed by any method such as a batch method, a semi-batch method, and a flow reaction method.
• the flow-type reaction method is preferable in that the reaction time can be easily controlled.
• the time for the heat treatment is preferably 0.1 to 30 minutes after the aqueous medium reaches the set temperature from the viewpoint of improving the solubility of ellagic acid and the thermal stability, and further 0.2 to 15 minutes, and further 0.5 ⁇ 8 minutes is preferred.
• the heat treatment time is an average residence time calculated by dividing the volume of the high-temperature and high-pressure part of the reactor by the supply rate of the aqueous medium.
• the flow rate of the aqueous medium in the case of the flow reaction method varies depending on the volume of the reactor. For example, when the reactor volume is 100 mL, 3.3 to 200 mL / min is preferable, and further 6.7 to 150 mL / min. Is preferred.
• the heat treatment liquid obtained by heat treatment it is preferable to include a step of cooling the heat treatment liquid obtained by heat treatment to 90 ° C. or less, preferably 50 ° C. or less, more preferably 30 ° C. or less.
• the heat treatment liquid may be mixed and stirred for 0.5 to 5 days, preferably 1 to 3 days.
• the cooling rate of the heat treatment liquid calculated from the time required to decrease from the heat treatment temperature to 90 ° C. is 0.1 ° C./s or more, further 0.2 ° C./s or more, and further 0.5 ° C./s or more. Further, it is preferably 1 ° C./s or more, further 3 ° C./s or more, more preferably 5 ° C./s or more, and further preferably 7 ° C./s or more.
• the higher the cooling rate the more the solubility of free ellagic acid can be improved. For this reason, although the upper limit of a cooling rate is not specifically defined, 100 degree C / s or less, for example, 50 degrees C / s or less are preferable from viewpoints, such as restrictions of manufacturing equipment.
• the method for removing the solid part is not particularly limited, and can be performed, for example, by centrifugation, decantation, or filtration.
• the form of the ellagic acid composition of the present invention may be in the form of an aqueous solution, or may be in the form of a paste by adjusting the amount of water.
• means for adjusting and removing moisture include freeze drying, evaporation to dryness, and spray drying.
• the heat-treated liquid When the heat-treated liquid is subjected to freeze-drying or spray-drying, it is preferable to spray-dry or freeze-dry the obtained heat-treated liquid within 300 minutes after completion of the heat treatment from the viewpoint of increasing the yield of ellagic acid. Of these, spray drying is preferred because it can be processed in a short time. “Within 300 minutes” after the end of the heat treatment is the time from the time when the heat treatment is finished, that is, the time when the heat treatment liquid is lowered to less than 100 ° C. to the start of spray drying or freeze drying.
• the time from the end of the heat treatment to the start of spray drying or freeze drying is preferably within 240 minutes, more preferably within 150 minutes, further within 120 minutes, and more preferably within 60 minutes. Further, 0.1 to 150 minutes is preferable, and further 0.1 to 60 minutes is preferable.
• the method of spray drying or freeze drying is not particularly limited, and a known method can be applied.
• the heat treatment liquid in the case of spray drying, can be sprayed from a nozzle and dropped by dropping in hot air at 100 to 220 ° C., preferably 130 to 190 ° C.
• the heat treatment liquid can be frozen in liquid nitrogen, a cool bath, a freezer, etc., crushed, sieved, and then dried by sublimating moisture in a vacuum.
• the freezing temperature of the heat treatment liquid is preferably ⁇ 70 to 0 ° C.
• the absolute pressure during drying is preferably from 0.1 to 1000 Pa, more preferably from 0.5 to 100 Pa, still more preferably from 1 to 10 Pa.
• the heat treatment liquid may be spray dried or freeze dried after being concentrated.
• a general method such as vacuum concentration can be used.
• the ellagic acid composition thus obtained is excellent in solubility in water because precipitation of free ellagic acid is suppressed even at room temperature.
• the solubility (25 ° C.) of free ellagic acid in the resulting ellagic acid composition is preferably 0.05 g / L or more, more preferably 0.08 g / L or more, and further preferably 0.15 g / L or more. is there.
• free ellagic acid can be dissolved in water.
• solubilization rate of free ellagic acid can be calculated by the formula described in the examples below.
• the ellagic acid composition of the present invention can be used for various foods and beverages, pharmaceuticals and the like.
• confectionery such as beverages, breads, noodles, cookies, snacks, jelly, dairy products, frozen foods, instant foods such as powdered coffee, starch processed products, processed meat products, and other processed foods , Liquid, solid or semi-solid foods and beverages such as seasonings and dietary supplements.
• pharmaceuticals include dosage forms such as tablets (such as chewable tablets), capsules, and powders.
• a step of preparing a heat-treated raw material by mixing a raw material containing a guava leaf extract and containing 1 to 5% by mass of free ellagic acid in a solid content and an aqueous medium, and the heat treatment A method for producing an ellagic acid composition comprising a step of heat-treating a raw material at 100 to 180 ° C.
• the content of the guava leaf extract is preferably 60% by mass or more, more preferably 70% by mass or more, more preferably 80% by mass or more, and further preferably 90% by mass or more, based on the solid content.
• the content of the guava leaf extract in the raw material is preferably 60 to 100% by mass, more preferably 70 to 100% by mass, still more preferably 80 to 100% by mass, and still more preferably 90%, based on the solid content.
• the method for producing an ellagic acid composition according to ⁇ 1> which is ⁇ 100 mass%, more preferably 95 to 100 mass%, further preferably 97 to 100 mass%, and more preferably 97 to 99.5 mass%.
• the content of free ellagic acid in the solid content of the raw material is preferably 1.2% by mass or more, more preferably 1.5% by mass or more, still more preferably 1.8% by mass or more, and still more preferably.
• the solid content is preferably 3 g / L or more, more preferably 3.5 g / L or more, still more preferably 4.0 g / L or more, and preferably 60 g / L.
• it is more preferably 50 g / L or less, preferably 3 to 60 g / L, more preferably 3.5 to 50 g / L, and still more preferably 4.0 to 50 g / L.
• the manufacturing method of the ellagic acid composition of any one of.
• the pH of the heat treatment raw material is preferably pH 4 or higher, more preferably pH 4.7 or higher, still more preferably pH 4.9 or higher, preferably pH 5.8 or lower, more preferably pH 5.5 or lower, More preferably, it is 5.4 or less, more preferably 5.3 or less, preferably pH 4 to 5.8, more preferably pH 5 to 5.5, still more preferably pH 4.7 to 5.4, still more preferably.
• the method for producing an ellagic acid composition according to any one of ⁇ 1> to ⁇ 5>, in which is 4.7 to 5.3.
• the aqueous medium is preferably water or an aqueous solution of water and an organic solvent, more preferably water or water and an alcohol aqueous solution having 4 or less carbon atoms, and further preferably water or water and an aqueous ethanol solution ⁇ 1.
• the temperature of the heat treatment is preferably 110 ° C. or higher, more preferably 120 ° C. or higher, preferably 170 ° C. or lower, more preferably 160 ° C. or lower, still more preferably 150 ° C.
• the ellagic acid composition according to any one of ⁇ 1> to ⁇ 7>, preferably 100 to 170 ° C., more preferably 110 to 170 ° C., more preferably 120 to 160 ° C., and still more preferably 120 to 150 ° C. Production method.
• the pressure during the heat treatment is preferably 0 to 10 MPa in gauge pressure, more preferably 0.1 to 8 MPa, more preferably 0.1 to 6 MPa, still more preferably 0.2 to 6 MPa, and still more preferably 0. ⁇ 1> to ⁇ 8>, wherein the pressure is 2 to 4 MPa, more preferably 0.25 to 2 MPa, still more preferably 0.3 to 1.5 MPa, and still more preferably 0.3 to 0.6 MPa.
• a method for producing an ellagic acid composition ⁇ 10>
• the heat treatment time is preferably 0.1 to 30 minutes, more preferably 0.2 to 15 minutes, and further preferably 0.5 to 8 minutes after the aqueous medium reaches the set temperature.
• ⁇ 1 >- ⁇ 9> The method for producing an ellagic acid composition according to any one of the above.
• a method for producing an ellagic acid composition ⁇ 12> In the step of cooling the heat treatment liquid, the cooling rate from the heat treatment temperature to 90 ° C.
• the method for producing an ellagic acid composition according to any one of ⁇ 1> to ⁇ 11>, which is not more than / s, more preferably not more than 50 ° C./s.
• the time from the end of the heat treatment to the start of spray drying or freeze drying is preferably within 240 minutes, more preferably within 150 minutes, still more preferably within 120 minutes, and even more preferably within 60 minutes.
• the method for producing an ellagic acid composition according to ⁇ 13> preferably 0.1 to 150 minutes, more preferably 0.1 to 60 minutes.
• ⁇ 15> The method for producing an ellagic acid composition according to ⁇ 13> or ⁇ 14>, wherein the heat treatment liquid obtained by the heat treatment is concentrated and then spray-dried or freeze-dried.
• ⁇ 16> An ellagic acid composition obtained by the production method according to any one of ⁇ 1> to ⁇ 15>.
• Quantification of free ellagic acid was performed by a gradient method using a Hitachi high-performance liquid chromatograph, equipped with an intact column Cadenza CD-C18 (4.6 mm ⁇ ⁇ 150 mm, 3 ⁇ m) and a column temperature of 40 ° C.
• the mobile phase A solution was 0.05 mol / L acetic acid aqueous solution
• the B solution was acetonitrile
• the solution was fed at 1.0 mL / min.
• the gradient conditions are as follows. Time (min) A liquid (%) B liquid (%) 0 99 1 10 90 10 20 85 15 40 10 90 50 10 90 50.1 85 15 60 85 15
• the sample injection amount was 10 ⁇ L and quantified by absorbance at a wavelength of 254 nm.
• the amount of free ellagic acid in the heat-treated raw material was determined by dissolving the heat-treated raw material in dimethyl sulfoxide, and filtering it with a hydrophilic polytetrafluoroethylene filter having a pore size of 0.2 ⁇ m at 25 ° C., and measuring the dissolved concentration. .
• solubility evaluation The solubility of the free ellagic acid in the ellagic acid composition after drying is determined by adding the ellagic acid composition to distilled water so that the solid content becomes the amount in the aqueous solution or suspension before drying. Then, after shaking for 5 minutes, it was determined by filtering with a cellulose acetate membrane filter having a pore size of 0.2 ⁇ m and measuring the dissolution concentration.
• Example 1 5.0 g of guava leaf extract powder (manufactured by Matsuura Pharmaceutical Co., Ltd., free ellagic acid content 2%) was added to 1250 mL of distilled water to prepare a heat treatment raw material, which was uniformly stirred in a slurry supply tank.
• the pH of the heat treatment raw material was 5.1.
• Table 1 shows the solid content concentration and free ellagic acid concentration in the heat-treated raw material, and the free ellagic acid concentration in the solid content of the raw material.
• the liquid in the slurry supply tank was supplied at a rate of 100 mL / min to a stainless steel flow reactor (with a volume of 100 mL, manufactured by Nitto Koatsu Co., Ltd.), and heat-treated at 110 ° C.
• the pressure was adjusted to 0.3 MPa (gauge pressure) with an outlet valve.
• the heat treatment liquid was extracted from the reactor outlet, cooled to room temperature (25 ° C.) with a heat exchanger, and recovered by returning the pressure to atmospheric pressure with an outlet valve.
• the cooling rate obtained from the cooling time from 110 ° C. to 90 ° C. was 7.88 ° C./s.
• a part of the heat treatment liquid was sampled, the amount of free ellagic acid dissolved in the aqueous medium was measured, and the solubilization rate was determined. Further, the pH of the heat treatment liquid was measured. Next, the heat-treated solution was pre-frozen in a ⁇ 50 ° C.
• an ellagic acid composition was obtained in the form of a powder. Using this ellagic acid composition powder, the amount of free ellagic acid dissolved in water was measured to determine the solubilization rate.
• Example 2 The treatment was performed in the same manner as in Example 1 except that the heat treatment temperature was 120 ° C.
• Example 3 The treatment was performed in the same manner as in Example 1 except that the heat treatment temperature was 150 ° C. and the gauge pressure was 0.6 MPa.
• Comparative Example 1 The same treatment as in Example 2 was carried out except that 0.11 g of ellagic acid dihydrate (manufactured by Wako Pure Chemical Industries, Ltd., free ellagic acid content 89%) was used without using guava leaf extract powder.
• the pH of the heat treatment raw material was 5.8.
• Table 1 shows the solid content concentration and free ellagic acid concentration in the heat-treated raw material, and the free ellagic acid concentration in the solid content of the raw material.
• Comparative Example 2 The treatment was performed in the same manner as in Example 1 except that the heat treatment temperature was 80 ° C.
• Example 4 The heat treatment liquid was recovered by the same treatment as in Example 2 except that 10 g of guava leaf extract powder was used.
• the pH of the heat treatment raw material was 5.0.
• Table 1 shows the solid content concentration and free ellagic acid concentration in the heat-treated raw material, and the free ellagic acid concentration in the solid content of the raw material.
• the heat treatment liquid is supplied to a spray dryer (manufactured by Yamato Scientific Co., Ltd., ADL311S, inlet air temperature 160 ° C., outlet air temperature 76 ° C.) at a flow rate of 6.5 g / min.
• An ellagic acid composition was obtained in the form of a powder.
• Example 5 The same treatment as in Example 4 was performed except that 25 g of guava leaf extract powder was used.
• the pH of the heat treatment raw material was 5.0.
• Table 1 shows the solid content concentration and free ellagic acid concentration in the heat-treated raw material, and the free ellagic acid concentration in the solid content of the raw material.
• Example 6 The same treatment as in Example 4 was conducted except that 62.5 g of guava leaf extract powder was used.
• the pH of the heat treatment raw material was 4.9.
• Table 1 shows the solid content concentration and free ellagic acid concentration in the heat-treated raw material, and the free ellagic acid concentration in the solid content of the raw material.
• Example 7 The same treatment as in Example 4 was conducted except that 10 g of guava leaf extract powder and 0.20 g of ellagic acid dihydrate were used.
• the pH of the heat treatment raw material was 5.1.
• Table 1 shows the solid content concentration and free ellagic acid concentration in the heat-treated raw material, and the free ellagic acid concentration in the solid content of the raw material.
• Comparative Example 3 The same treatment as in Example 4 was conducted except that 10 g of guava leaf extract powder and 0.45 g of ellagic acid dihydrate were used.
• the pH of the heat treatment raw material was 5.1.
• Table 1 shows the solid content concentration and free ellagic acid concentration in the heat-treated raw material, and the free ellagic acid concentration in the solid content of the raw material.
• Example 8 2.0 g of guava leaf extract powder (manufactured by Matsuura Pharmaceutical Co., Ltd., free ellagic acid content 2%) was added to 100 mL of distilled water to prepare a heat treatment raw material.
• the pH of the heat treatment raw material was 5.0.
• Table 1 shows the solid content concentration and free ellagic acid concentration in the heat-treated raw material, and the free ellagic acid concentration in the solid content of the raw material.
• the heat treatment was performed in a stainless batch reactor (manufactured by Nitto Koatsu Co., Ltd.) having an internal volume of 190 mL. After reaching 120 ° C. and holding for 1 minute, the reactor was immersed in a cold water bath and cooled to room temperature (25 ° C.).
• the cooling rate obtained from the cooling time from 120 ° C. to 90 ° C. was 0.55 ° C./s.
• the heat treatment liquid is supplied to a spray dryer (manufactured by Yamato Scientific Co., Ltd., ADL311S, inlet air temperature 160 ° C., outlet air temperature 76 ° C.) at a flow rate of 6.5 g / min.
• An ellagic acid composition was obtained in the form of a powder.
• Example 9 After obtaining the heat treatment liquid in the same manner as in Example 5, 300 minutes after completion of the heat treatment, it was supplied to the spray dryer to obtain an ellagic acid composition in the form of powder.
• Example 10 After obtaining the heat treatment liquid in the same manner as in Example 2, it was concentrated to 5 times the concentration with an evaporator, and supplied to the spray dryer 120 minutes after the end of the heat treatment, and in the form of powder as in Example 4. Thus, an ellagic acid composition was obtained.
• Example 11 The same processing as in Example 2 was performed except that 5 g of guavaphenone (manufactured by Bizen Kasei Co., Ltd., ellagic acid content 1.2%) was used as the guava leaf extract powder.
• the pH of the heat treatment raw material was 5.2.
• Table 1 shows the solid content concentration and free ellagic acid concentration in the heat-treated raw material, and the free ellagic acid concentration in the solid content of the raw material.
• Table 1 shows the results of Examples 1 to 11 and Comparative Examples 1 to 3.
• Example 12 The treatment was performed in the same manner as in Example 1 except that the heat treatment temperature was 100 ° C.
• Example 13 800 g of 50% aqueous ethanol heated to 65 ° C. was added to 40 g of guava tea leaves (manufactured by Okinawa Turmeric), and extracted with stirring for 5 minutes. Thereafter, the mixture was ice-cooled, roughly filtered with a metal mesh, and filtered under reduced pressure with 5C filter paper to obtain an extract. After concentration with an evaporator, the extract was freeze-dried to obtain a guava leaf extract having a solid content of 7.8 g. The content of free ellagic acid in the obtained guava leaf extract was 1.5%. The same processing as in Example 2 was performed except that the obtained guava leaf extract was used as the guava leaf extract powder. The pH of the heat treatment raw material was 5.4. Moreover, the free ellagic acid concentration in the heat-treated raw material was as shown in Table 3.
• Comparative Example 5 The concentration of ellagic acid dissolved in the above HPLC after dispersing the guava leaf extract (ellagic acid content 1.5%) obtained in Example 13 in distilled water and filtering through a 0.2 ⁇ m cellulose acetate membrane disk filter. was measured. The results of Example 13 and Comparative Example 5 are shown in Table 3.

Landscapes

• Chemical & Material Sciences (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Organic Chemistry (AREA)
• Polymers & Plastics (AREA)
• Nutrition Science (AREA)
• Engineering & Computer Science (AREA)
• Food Science & Technology (AREA)
• Animal Behavior & Ethology (AREA)
• Public Health (AREA)
• Pharmacology & Pharmacy (AREA)
• Medicinal Chemistry (AREA)
• Veterinary Medicine (AREA)
• General Health & Medical Sciences (AREA)
• Botany (AREA)
• Mycology (AREA)
• Epidemiology (AREA)
• Biochemistry (AREA)
• Toxicology (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Coloring Foods And Improving Nutritive Qualities (AREA)
• Cosmetics (AREA)

Priority Applications (2)

Applications Claiming Priority (2)

Publications (1)

Family

ID=52279749

Family Applications (1)

Country Status (4)

Cited By (1)

Families Citing this family (1)

Citations (6)

Family Cites Families (5)

• 2014
  • 2014-06-13 CN CN201480038872.5A patent/CN105357983B/zh active Active
  • 2014-06-13 US US14/904,014 patent/US9822091B2/en active Active
  • 2014-06-13 JP JP2014122000A patent/JP6454094B2/ja active Active
  • 2014-06-13 WO PCT/JP2014/065694 patent/WO2015005060A1/ja not_active Ceased

Patent Citations (6)

Also Published As

Similar Documents

Legal Events